Desenex Powder Zinc undecylenate 20% w/w Undecylenic Acid 2.0% w/w

País: Irlanda

Língua: inglês

Origem: HPRA (Health Products Regulatory Authority)

Ingredientes ativos:

Zinc undecylenate; Undecylenic acid

Disponível em:

Clonmel Healthcare Ltd

Código ATC:

D01AE; D01AE04

DCI (Denominação Comum Internacional):

Zinc undecylenate; Undecylenic acid

Dosagem:

20/2 percent weight/weight

Forma farmacêutica:

Cutaneous powder

Tipo de prescrição:

Product not subject to medical prescription

Área terapêutica:

Other antifungals for topical use; undecylenic acid

Status de autorização:

Marketed

Data de autorização:

1998-03-20

Características técnicas

Health Products Regulatory Authority
26 June 2020
CRN009671
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Desenex Powder Zinc undecylenate 20% w/w Undecylenic Acid 2.0% w/w
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Zinc Undecylenate 20.0 % w/w
Undecylenic Acid 2.0 % w/w
Excipients with known effect
Also includes benzyl benzoate maximum 0.25% w/w.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cutaneous powder (powder).
White free-flowing powder, free from lumps and grit.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Desenex is recommended in the prophylaxis and treatment of mycotic
superficial dermatophytoses of feet and relief of itching
and scaling produced by these fungal infections. Is it also used to
remove foot odour and prevent sweating.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
For topical administration only.
_General directions: _
Apply Desenex Powder liberally over the affected areas as required
after washing and drying.
_Feet:_
Twice daily, sprinkle powder liberally between toes, on feet, and in
the shoes and socks.
Continue treatment for two weeks after symptoms disappear. If there is
no improvement after 2 weeks treatment or symptoms
worsen consult your doctor or pharmacist.
To prevent reinfection, use Desenex Powder daily.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not recommended for nail or scalp infections.
Do not use on children under 2 years of age except under the advice
and supervision of a doctor.
If there is no response within 2 weeks, or the condition is
aggravated, use of the product should be stopped and the physician
should be notified.
Health Products Regulatory Authority
26 June 2020
CRN009671
Page 2 of 4
Desenex Powder contains benzyl benzoate which may cause local
irritation.
Do not apply to broken skin
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTIONS
None stated.
4